Efficacy and safety of autologous stem cell transplantation for decompensated liver cirrhosis: A retrospective cohort study

Table 2 Comparison of the survival rate and incidence of liver cancer between the stem cell transplantation group and the non-transplantation group

	Time	Stem cell transplantation group	Non-transplantation group	χ2 value	P-value
		(n = 23)	(n = 69)
Survival rate	3-mo	95.70%	84.10%	0.951	0.33
	6-mo	91.30%	82.60%
	1-yr	87.00%	73.80%
	2-yr	73.90%	62.90%
	3-yr	50.80%	58.10%
	4-yr	46.20%	54.50%
	5-yr	41.60%	50.70%
	6-yr	32.30%	44.20%
	7-yr	24.30%	39.50%
Incidence of liver cancer	3-mo	0	0	6.3	0.011
	6-mo	4.80%	1.70%
	1-yr	9.50%	5.50%
	2-yr	20.80%	14.10%
	3-yr	41.40%	19.30%
	4-yr	49.80%	22.40%
	5-yr	66.50%	29.00%
	6-yr	66.50%	36.30%
	7-yr	83.30%	42.70%